Clinical Trial Update: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GLS4 in combination with ritonavir for chronic hepatitis B infection has been completed, assessing safety, tolerability, and antiviral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GLS4 (GLS4)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Chronic HBV Infection | Phase 2 | Status: COMPLETED